Region-specific expression of vesicular glutamate and GABA transporters under various ischaemic conditions in mouse forebrain and retina

Neuroscience

Volumn 231, Issue , 2013, Pages 328-344

  Michalski, D ^a   Hartig W ^a   Krugel K ^a   Edwards, R H ^b   Boddener M ^c   Bohme L ^a   Pannicke, T ^a   Reichenbach, A ^a   Grosche, A ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SYNAPTIC SYSTEMS GMBH   (Germany)

Author keywords

Cerebral ischaemia; GABA; Glutamate; Retinal ischaemia; Vesicular transporter

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; MICROTUBULE ASSOCIATED PROTEIN 2; VESICULAR GLUTAMATE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CELL NUCLEUS; CENTRAL RETINA ARTERY OCCLUSION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOREBRAIN; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; INTRAOCULAR HYPERTENSION; LATERAL HYPOTHALAMUS; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NEOCORTEX; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; RETINA ISCHEMIA; SUBCORTEX;

ANIMALS; BRAIN ISCHEMIA; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; ISCHEMIA; MICE; PROSENCEPHALON; RETINA; RETINAL VESSELS; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 84872287948     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.046     Document Type: Article

References (75)

1. Albers G.W., Goldstein L.B., Hall D., Lesko L.M. Aptiganel hydrochloride in acute ischaemic stroke: a randomized controlled trial. JAMA 2001, 286:2673-2682.
2. Amilhon B., Lepicard E., Renoir T., Mongeau R., Popa D., Poirel O., Miot S., Gras C., Gardier A.M., Gallego J., Hamon M., Lanfumey L., Gasnier B., Giros B., El Mestikawy S. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J Neurosci 2010, 30:2198-2210.
3. Benjelloun N., Renolleau S., Represa A., Ben-Ari Y., Charriaut-Marlangue C. Inflammatory responses in the cerebral cortex after ischaemia in the P7 neonatal rat. Stroke 1999, 30:1916-1923.
4. Blakely R.D., Edwards R.H. Vesicular and plasma membrane transporters for neurotransmitters. Cold Spring Harb Perspect Biol 2012, 4. pii:a005595.
5. Broussard J.I. Co-transmission of dopamine and glutamate. J Gen Physiol 2012, 139:93-96.
6. Buchan A.M., Slivka A., Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res 1992, 574:171-177.
7. Buckingham B.P., Inman D.M., Lambert W., Oglesby E., Calkins D.J., Steele M.R., Vetter M.L., Marsh-Armstrong N., Horner P.J. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci 2008, 28:2735-2744.
8. Candelario-Jalil E. Injury and repair mechanisms in ischaemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 2009, 10:644-654.
9. Chen C.S., Lee A.W., Campbell B., Lee T., Paine M., Fraser C., Grigg J., Markus R. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke 2011, 42:2229-2234.
10. Cueva J.G., Haverkamp S., Reimer R.J., Edwards R., Wässle H., Brecha N.C. Vesicular gamma-aminobutyric acid transporter expression in amacrine and horizontal cells. J Comp Neurol 2002, 445:227-237.
11. Dal Bo G., Bérubé-Carrière N., Mendez J.A., Leo D., Riad M., Descarries L., Lévesque D., Trudeau L.E. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Neuroscience 2008, 156:59-70.
12. Dijk F., van Leeuwen S., Kamphuis W. Differential effects of ischemia/reperfusion on amacrine cell subtype-specific transcript levels in the rat retina. Brain Res 2004, 1026:194-204.
13. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
14. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
15. Durukan A., Tatlisumak T. Acute ischaemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischaemia. Pharmacol Biochem Behav 2007, 87:179-197.
16. Edwards R.H. The neurotransmitter cycle and quantal size. Neuron 2007, 55:835-858.
17. El Mestikawy S., Wallén-Mackenzie A., Fortin G.M., Descarries L., Trudeau L.E. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat Rev Neurosci 2011, 12:204-216.
18. Enblad P., Frykholm P., Valtysson J., Silander H.C., Andersson J., Fasth K.J., Watanabe Y., Långström B., Hillered L., Persson L. Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography. Stroke 2001, 32:1574-1580.
19. Endres M., Dirnagl U. Ischemia and stroke. Adv Exp Med Biol 2002, 513:455-473.
20. Endres M., Engelhardt B., Koistinaho J., Lindvall O., Meairs S., Mohr J.P., Planas A., Rothwell N., Schwaninger M., Schwab M.E., Vivien D., Wieloch T., Dirnagl U. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 2008, 25:268-278.
21. Fremeau R.T., Burman J., Qureshi T., Tran C.H., Proctor J., Johnson J., Zhang H., Sulzer D., Copenhagen D.R., Storm-Mathisen J., Reimer R.J., Chaudhry F.A., Edwards R.H. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A 2002, 99:14488-14493.
22. Fremeau R.T., Voglmaier S., Seal R.P., Edwards R.H. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 2004, 27:98-103.
23. Ginsberg M.D. Neuroprotection in brain ischaemia: an update (part I). Neuroscientist 1995, 1:95-193.
24. Ginsberg M.D. Neuroprotection for ischaemic stroke: past, present and future. Neuropharmacology 2008, 55:363-389.
25. Gras C., Herzog E., Bellenchi G.C., Bernard V., Ravassard P., Pohl M., Gasnier B., Giros B., El Mestikawy S. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 2002, 22:5442-5451.
26. Gras C., Amilhon B., Lepicard E.M., Poirel O., Vinatier J., Herbin M., Dumas S., Tzavara E.T., Wade M.R., Nomikos G.G., Hanoun N., Saurini F., Kemel M.L., Gasnier B., Giros B., El Mestikawy S. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci 2008, 11:292-300.
27. + amacrine cells. Vis Neurosci 2011, 28:381-392.
28. Guzman M.S., De Jaeger X., Raulic S., Souza I.A., Li A.X., Schmid S., Menon R.S., Gainetdinov R.R., Caron M.G., Bartha R., Prado V.F., Prado M.A. Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biol 2011, 9:e1001194.
29. Hacke W., Schwab S., Horn M., Spranger M., De Georgia M., von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996, 53:309-315.
30. Hacke W., Kaste M., Bluhmki E., Brozman M., Dávalos A., Guidetti D., Larrue V., Lees K.R., Medeghri Z., Machnig T., Schneider D., von Kummer R., Wahlgren N., Toni D. Thrombolysis with alteplase 3 to 4.5 hours after acute ischaemic stroke. N Engl J Med 2008, 359:1317-1329. ECASS Investigators.
31. Harkany T., Härtig W., Berghuis P., Dobszay M.B., Zilberter Y., Edwards R.H., Mackie K., Ernfors P. Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling by cholinergic neurons. Eur J Neurosci 2003, 18:1979-1992.
32. Harkany T., Holmgren C., Härtig W., Qureshi T., Chaudhry F.A., Storm-Mathisen J., Dobszay M.B., Berghuis P., Schulte G., Sousa K.M., Fremeau R.T., Edwards R.H., Mackie K., Ernfors P., Zilberter Y. Endocannabinoid-independent retrograde signalling at inhibitory synapses in layer 2/3 of neocortex: involvement of vesicular transporter 3. J Neurosci 2004, 24:4978-4988.
33. Hársing L.G., Gigler G., Albert M., Szénási G., Simó A., Móricz K., Varga A., Ling I., Bagdy E., Király I., Sólyom S., Jurányi Z. Neurotransmitter release in experimental stroke models: the role of glutamate-GABA interaction. Adv Exp Med Biol 2004, 541:21-37.
34. Haverkamp S., Wässle H. Characterization of an amacrine cell type of the mammalian retina immunoreactive for vesicular glutamate transporter 3. J Comp Neurol 2004, 468:251-263.
35. Hayreh S.S., Zimmerman M.B. Central retinal artery occlusion: visual outcome. Am J Ophthalmol 2005, 140:376-391.
36. Hazin R., Dixon J.A., Bhatti M.T. Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy?. Curr Opin Ophthalmol 2009, 20:210-218.
37. Herzog E., Gilchrist J., Gras C., Muzerelle A., Ravassard P., Giros B., Gaspar P., El Mestikawy S. Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience 2004, 123:983-1002.
38. Hirrlinger P.G., Ulbricht E., Iandiev I., Reichenbach A., Pannicke T. Alterations in protein expression and membrane properties during Müller cell gliosis in a murine model of transient retinal ischemia. Neurosci Lett 2010, 472:73-78.
39. Imbrosci B., Mittmann T. Functional consequences of the disturbances in the GABA-mediated inhibition induced by injuries in the cerebral cortex. Neural Plast 2011, 2011:614329.
40. Johnson J., Tian N., Caywood M.S., Reimer R.J., Edwards R.H., Copenhagen D.R. Vesicular neurotransmitter transporter expression in developing postnatal rodent retina: GABA and glycine precede glutamate. J Neurosci 2003, 23:518-529.
41. Kanemitsu H., Nakagomi T., Tamura A., Tsuchiya T., Kono G., Sano K. Differences in the extent of primary ischaemic damage between middle cerebral artery coagulation and intraluminal occlusion models. J Cereb Blood Flow Metab 2002, 22:1196-1204.
42. Kaneko T., Fujiyama F., Hioki H. Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain. J Comp Neurol 2002, 444:39-62.
43. Kaur C., Foulds W.S., Ling E.A. Hypoxia-ischaemia and retinal ganglion cell damage. Clin Ophthalmol 2008, 2:879-889.
44. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
45. Kim D.S., Kwak S.E., Kim J.E., Jung J.Y., Won M.H., Choi S.Y., Kwon O.S., Kang T.C. Transient ischaemia affects plasma membrane glutamate transporter, not vesicular glutamate transporter, expressions in the gerbil hippocampus. Anat Histol Embryol 2006, 35:265-270.
46. Kolominsky-Rabas P.L., Sarti C., Heuschmann P.U., Graf C., Siemonsen S., Neundoerfer B., Katalinic A., Lang E., Gassmann K.G., von Stockert T.R. A prospective community-based study of stroke in Germany - the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke 1998, 29:2501-2506.
47. Kroemer G., El-Deiry W.S., Golstein P., Peter M.E., Vaux D., Vandenabeele P., Zhivotovsky B., Blagosklonny M.V., Malorni W., Knight R.A., Piacentini M., Nagata S., Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005, 12(Suppl. 2):1463-1467. Nomenclature Committee on Cell Death.
48. Leavitt J.A., Larson T.A., Hodge D.O., Gullerud R.E. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 2011, 152:820-823.
49. Lehrmann E., Christensen T., Zimmer J., Diemer N.H., Finsen B. Microglial and macrophage reactions mark progressive changes and define the penumbra in the rat neocortex and striatum after transient middle cerebral artery occlusion. J Comp Neurol 1997, 386:461-476.
50. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
51. McCulloch J., Ozyurt E., Park C.K., Nehls D.G., Teasdale G.M., Graham D.I. Glutamate receptor antagonists in experimental focal cerebral ischaemia. Acta Neurochir Suppl 1993, 57:73-79.
52. Nickerson Poulin A., Guerci A., El Mestikawy S., Semba K. Vesicular glutamate transporter 3 immunoreactivity is present in cholinergic basal forebrain neurons projecting to the basolateral amygdala in rat. J Comp Neurol 2006, 498:690-711.
53. Nucci C., Tartaglione R., Rombolà L., Morrone L.A., Fazzi E., Bagetta G. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 2005, 26:935-941.
54. Omote H., Miyaji T., Juge N., Moriyama Y. Vesicular neurotransmitter transporter: bioenergetics and regulation of glutamate transport. Biochemistry 2011, 50:5558-5565.
55. Popp A., Jaenisch N., Witte O.W., Frahm C. Identification of ischaemic regions in a rat model of stroke. PLoS One 2009, 4:e4764.
56. Qin Z.H., Wang Y., Chase T.N. Stimulation of N-methyl-d-aspartate receptors induces apoptosis in rat brain. Brain Res 1996, 725:166-176.
57. Reimer R.J., Fon E.A., Edwards R.H. Vesicular neurotransmitter transport and the presynaptic regulation of quantal size. Curr Opin Neurobiol 1998, 8:405-412.
58. Ren J., Qin C., Hu F., Tan J., Qiu L., Zhao S., Feng G., Luo M. Habenula "cholinergic" neurons corelease glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron 2011, 69:445-452.
59. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000, 403:316-321.
60. Russo R., Cavaliere F., Berliocchi L., Nucci C., Gliozzi M., Mazzei C., Tassorelli C., Corasaniti M.T., Rotiroti D., Bagetta G., Morrone L.A. Modulation of pro-survival and death-associated pathways under retinal ischaemia/reperfusion: effects of NMDA receptor blockade. J Neurochem 2008, 107:1347-1357.
61. Sánchez-Mendoza E., Burguete M.C., Castelló-Ruiz M., González M.P., Roncero C., Salom J.B., Arce C., Cañadas S., Torregrosa G., Alborch E., Oset-Gasque M.J. Transient focal cerebral ischaemia significantly alters not only EAATs but also VGLUTs expression in rats: relevance of changes in reactive astroglia. J Neurochem 2010, 113:1343-1355.
62. Schäfer M.K., Varoqui H., Defamie N., Weihe E., Erickson J.D. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem 2002, 277:50734-50748.
63. Schumacher M., Schmidt D., Jurklies B., Gall C., Wanke I., Schmoor C., Maier-Lenz H., Solymosi L., Brueckmann H., Neubauer A.S., Wolf A., Feltgen N. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 2010, 117:1367-1375.e1. EAGLE-Study Group.
64. Seal R.P., Akil O., Yi E., Weber C.M., Grant L., Yoo J., Clause A., Kandler K., Noebels J.L., Glowatzki E., Lustig L.R., Edwards R.H. Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron 2008, 57:263-275.
65. Steele E.C., Guo Q., Namura S. Filamentous middle cerebral artery occlusion causes ischaemic damage to the retina in mice. Stroke 2008, 39:2099-2104.
66. Stella S.L., Li S., Sabatini A., Vila A., Brecha N.C. Comparison of the ontogeny of the vesicular glutamate transporter 3 (VGLUT3) with VGLUT1 and VGLUT2 in the rat retina. Brain Res 2008, 1215:20-29.
67. Stornetta R.L., Sevigny C.P., Schreihofer A.M., Rosin D.L., Guyenet P.G. Vesicular glutamate transporter DNPI/VGLUT2 is expressed by both C1 adrenergic and nonaminergic presympathetic vasomotor neurons of the rat medulla. J Comp Neurol 2002, 444:207-220.
68. Sucher N.J., Lipton S.A., Dreyer E.B. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 1997, 37:3483-3493.
69. Szabadfi K., Mester L., Reglodi D., Kiss P., Babai N., Racz B., Kovacs K., Szabo A., Tamas A., Gabriel R., Atlasz T. Novel neuroprotective strategies in ischaemic retinal lesions. Int J Mol Sci 2010, 11:544-561.
70. Takamori S. VGLUTs: 'exciting' times for glutamatergic research?. Neurosci Res 2006, 55:343-351.
71. Varga V., Losonczy A., Zemelman B.V., Borhegyi Z., Nyiri G., Domonkos A., Hangya B., Holderith N., Magee J.C., Freund T.F. Fast synaptic subcortical control of hippocampal circuits. Science 2009, 326:449-453.
72. +/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J Neurosci 2002, 22:142-155.
73. Vemuganti R. Decreased expression of vesicular GABA transporter, but not vesicular glutamate, acetylcholine and monoamine transporters in rat brain following focal ischaemia. Neurochem Int 2005, 47:136-142.
74. Wässle H., Regus-Leidig H., Haverkamp S. Expression of the vesicular glutamate transporter vGluT2 in a subset of cones of the mouse retina. J Comp Neurol 2006, 496:544-555.
75. Young A.R., Ali C., Duretête A., Vivien D. Neuroprotection and stroke: time for a compromise. J Neurochem 2007, 103:1302-1309.